- European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancerPublication without faculty affiliation
- Olaparib as a maintenance therapy in newly diagnosed patients with ovarian cancer - SOLO1 study results2022 | Third Faculty of Medicine
- Olaparib - the first PARP inhibitor in the treatment of malignant tumors2015 | First Faculty of Medicine
- DNA Damage Signaling in Human Skin Cells Exposed to Hexavalent Chromium +12009 | Faculty of Medicine in Hradec Králové
- DNA Damage Signaling in Human Skin Cells Exposed to Hexavalent Chromium2009 | First Faculty of Medicine
- Parp1 hyperactivity couples DNA breaks to aberrant neuronal calcium signalling and lethal seizures2021 | Central Library of Charles University
- Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair2020 | Central Library of Charles University